TY - JOUR
T1 - Antimicrobial Stewardship from Policy to Practice
T2 - Experiences from UK Antimicrobial Pharmacists
AU - Gilchrist, Mark
AU - Wade, Paul
AU - Ashiru-Oredope, Diane
AU - Howard, Philip
AU - Sneddon, Jacqueline
AU - Whitney, Laura
AU - Wickens, Hayley
N1 - Publisher Copyright:
© 2015, The Author(s).
PY - 2015/9/22
Y1 - 2015/9/22
N2 - Antimicrobial stewardship in the UK has evolved dramatically in the last 15 years. Factors driving this include initial central funding for specialist pharmacists and mandatory reductions in healthcare-associated infections (particularly Clostridium difficile infection). More recently, the introduction of national stewardship guidelines, and an increased focus on stewardship as part of the UK five-year antimicrobial resistance strategy, have accelerated and embedded developments. Antimicrobial pharmacists have been instrumental in effecting changes at an organizational and national level. This article describes the evolution of the antimicrobial pharmacist role, its impact, the progress toward the actions listed in the five-year resistance strategy, and novel emerging areas in stewardship in the UK.
AB - Antimicrobial stewardship in the UK has evolved dramatically in the last 15 years. Factors driving this include initial central funding for specialist pharmacists and mandatory reductions in healthcare-associated infections (particularly Clostridium difficile infection). More recently, the introduction of national stewardship guidelines, and an increased focus on stewardship as part of the UK five-year antimicrobial resistance strategy, have accelerated and embedded developments. Antimicrobial pharmacists have been instrumental in effecting changes at an organizational and national level. This article describes the evolution of the antimicrobial pharmacist role, its impact, the progress toward the actions listed in the five-year resistance strategy, and novel emerging areas in stewardship in the UK.
KW - Antibiotic
KW - Antimicrobial stewardship
KW - Healthcare-associated infections
KW - Pharmacy
KW - Resistance
UR - https://www.scopus.com/pages/publications/84965010469
U2 - 10.1007/s40121-015-0080-z
DO - 10.1007/s40121-015-0080-z
M3 - Review article
AN - SCOPUS:84965010469
SN - 2193-8229
VL - 4
SP - 51
EP - 64
JO - Infectious Diseases and Therapy
JF - Infectious Diseases and Therapy
ER -